Nisa Investment Advisors’s Stoke Therapeutics STOK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $31K | Sell |
2,732
-28
| -1% | -$318 | ﹤0.01% | 1739 |
|
|
2025
Q1 | $18.4K | Buy |
2,760
+56
| +2% | +$372 | ﹤0.01% | 1916 |
|
|
2024
Q4 | $29.8K | Buy |
2,704
+10
| +0.4% | +$110 | ﹤0.01% | 1812 |
|
|
2024
Q3 | $33.1K | Sell |
2,694
-295
| -10% | -$3.63K | ﹤0.01% | 1750 |
|
|
2024
Q2 | $40.4K | Buy |
2,989
+1,038
| +53% | +$14K | ﹤0.01% | 1726 |
|
|
2024
Q1 | $26.3K | Buy |
1,951
+17
| +0.9% | +$230 | ﹤0.01% | 1804 |
|
|
2023
Q4 | $10.2K | Buy |
1,934
+1,869
| +2,875% | +$9.83K | ﹤0.01% | 2041 |
|
|
2023
Q3 | $256 | Buy |
65
+17
| +35% | +$67 | ﹤0.01% | 2633 |
|
|
2023
Q2 | $510 | Sell |
48
-800
| -94% | -$8.5K | ﹤0.01% | 2555 |
|
|
2023
Q1 | $7K | Buy |
848
+800
| +1,667% | +$6.6K | ﹤0.01% | 2210 |
|
|
2022
Q4 | $0 | Buy |
+48
| New | – | ﹤0.01% | 2714 |
|